Cargando…
The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19
BACKGROUND: The dual COVID-19 and overdose emergencies amplified strain on healthcare systems tasked with responding to both. One downstream consequence of the pandemic in the USA and Canada was a surge in drug overdoses resulting from public health-restricted access to services and an increasingly...
Autores principales: | McCrae, Karen, Glegg, Stephanie, Goyer, Marie-Éve, Le Foll, Bernard, Brar, Rupi, Sutherland, Christy, Fairbairn, Nadia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281344/ https://www.ncbi.nlm.nih.gov/pubmed/35836189 http://dx.doi.org/10.1186/s12954-022-00657-x |
Ejemplares similares
-
“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada
por: Glegg, Stephanie, et al.
Publicado: (2022) -
Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
por: Eydt, Erin, et al.
Publicado: (2021) -
Specification for unregulated power supply 70V, 2700A
por: Jamsek, J
Publicado: (1979) -
Towards cross-Canada monitoring of the unregulated street drug supply
por: Biggar, Emily, et al.
Publicado: (2021) -
Invited Commentary: Drug Checking for Novel Insights Into the Unregulated Drug Supply
por: Dasgupta, Nabarun, et al.
Publicado: (2021)